Alterations of the retinoblastoma gene in clinically localized, stage B prostate adenocarcinomas

Human Pathology

Volumn 27, Issue 1, 1996, Pages 28-34

  Ittmann, Michael M ^a   Wieczorek, Rosemary ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

chromosome 13; immunohistochemistry; tumor suppressor genes

Indexed keywords

RETINOBLASTOMA PROTEIN;

ARTICLE; CANCER STAGING; CHROMOSOME 13Q; CHROMOSOME LOSS; GENE DELETION; GENE REARRANGEMENT; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROSTATE ADENOCARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0030024671     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(96)90134-3     Document Type: Article

References (28)

1. Horowitz JM, Park S-H, Bogenmann E, et al: Frequent inactivation of retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc Natl Acad Sci U S A 87:2775-2779, 1990
2. Wadayama B, Toguchida J, Shimizu T, et al: Mutation spectrum of the retinoblastoma gene in osteosarcomas. Cancer Res 54:3042-3048, 1994
3. Cance WG, Brennan MF, Dudas ME, et al: Altered expression of the retinoblastoma gene product in human sarcomas. N Engl J Med 323:1457-1462, 1990
4. Wunder JS, Czitrom AA, Kandel R, et al: Analysis of alterations in the retinoblastoma gene and tumor grade in bone and soft-tissue sarcomas. J Natl Cancer Inst 83:194-200, 1991
5. IshikawaJ, Xu HJ, Hu S-X, et al: Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas. Cancer Res 51:5736-5743, 1991
6. Xu HJ, Cairns P, Hu S-X, et al: Loss of Rb protein expression in primary bladder cancer correlates with loss of heterozygosity at the Rb locus and tumor progression. Int J Cancer 53:781-784, 1993
7. Cordon-Cardo C, Wartinger D, Petrylak D, et al: Altered expression of the retinoblastoma gene product: Prognostic indicator in bladder cancer. J Natl Cancer Inst 84:1251-1261, 1992
8. Reissmann PT, Koga H, Takahashi R, et al: Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. Oncogene 8:1913-1919, 1993
9. Boynton RF, Huang Y, Blount PL, et al: Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers. Cancer Res 51:5766-5769, 1991
10. Borg A, Zhang Q-X, Aim P, et al: The retinoblastoma gene in breast cancer: Allele loss is not correlated with loss of gene protein expression. Cancer Res 52:2991-2994, 1992
11. Venter DJ, Bevan KL, Ludwig RL, et al: Retinoblastoma gene deletions in human glioblastomas. Oncogene 6:445-448, 1991
12. Kornblau SM, Xu HJ, del Giglio A, et al: Clinical implications of decreased retinoblastoma protein expression in acute myelogenous leukemia. Cancer Res 52:4587-4590, 1992
13. Carter B, Ewing C, Ward W, et al: Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 87:8751-8755, 1990
14. Brooks J, Bova S, Issacs W: Allelic loss of the retinoblastoma gene in primary human prostatic adenocarcinoma. The Prostate 26:35-39, 1995
15. Bookstein R, Shew J, Chen P, et al: Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science 247:712-715, 1989
16. Bookstein R, Rio P, Madreperla SA, et al: Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc Natl Acad Sci U S A 87:7762-7766, 1990
17. Geradts J, Hu S, Lincoln C, et al: Aberrant RB gene expression in routinely processed, archival tumor tissues determined by three different anti-RB antibodies. Int J Cancer 58:161-167, 1994
18. Phillips S, Morton D, Wallace D, et al: Loss of heterozygosity of the retinoblastoma and adenomatous polyposis susceptibility loci and in chromosomes 10p, 10q and 16q in human prostate cancer. Br J Urol 73:390-393, 1994
19. Sarkar FH, Sakr W, Li Y-W, et al: Analysis of retinoblastoma (RB) gene deletion in human prostatic carcinomas. The Prostate 21:145-152, 1992
20. Ittmann M, Greco A, Basilico C: Isolation of the human gene that complements a temperature-sensitive cell cycle mutation in BHK cells. Mol Cell Biol 7:3386-3393, 1987
21. Sambrook J, Fritsch E, Maniatis T: Molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory, NY, 1989, pp 9.34-9.55
22. Yandell D, Dryja T: Detection of DNA sequence polymorphisms by enzymatic amplification and direct genomic sequencing. Am J Hum Genet 45:547-555, 1989
23. Ittmann M, Wieczorek R, Heller P, et al: Alterations in the p53 and MDM-2 genes are infrequent in clinically localized Stage B prostate adenocarcinomas. Am J Pathol 145:287-293, 1994
24. Wooster R, Neuhausen S, Mangion J, et al: Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265:2088-2090, 1994
25. Tulinius H, Egilsson V, Olafsdottir G, et al: Risk of prostate, ovarian and endometrial cancer among relatives of women with breast cancer. Br Med J 305:855-857, 1992
26. Yoo G, Xu H, Brennan J, et al: Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. Cancer Res 54:4603-4606, 1994
27. Kim T, Benedict W, Xu H, et al: Loss of heterozygosity on chromosome 13 is common only in the biologically more aggressive subtypes of ovarian epithelial tumors and is associated with normal retinoblastoma gene expression. Cancer Res 54:605-609, 1994
28. Brown A, Ross F, Dunne E, et al: Evidence for a new tumor suppressor locus (DBM) in human B-cell neoplasia telomeric to the retinoblastoma gene. Nat Genet 3:67-72, 1993